Helius Medical Technologies (NASDAQ:HSDT) is a medical technology company focused on developing, licensing, and acquiring innovative medical products designed to amplify the brain's ability to heal itself. The company is primarily known for its pioneering work in neuromodulation, aiming to provide new solutions for patients suffering from neurological symptoms caused by disease or trauma. At the core of its operations is the development of its flagship product, the Portable Neuromodulation Stimulator (PoNS™) device, which represents a groundbreaking approach in non-invasive neurotherapy for the treatment of neurological symptoms. Helius Medical Technologies is passionately committed to improving patient outcomes and advancing neuroscientific understanding, striving to expand its portfolio through ongoing research and strategic collaborations.